WeightWatchers Announces Executive Leadership Transition
WeightWatchers (NASDAQ: WW) announced a significant leadership change on Sept. 27, 2024. Tara Comonte, an independent board member, has been appointed as Interim Chief Executive Officer, succeeding Sima Sistani, who is stepping down from her roles as CEO and board member.
During her tenure, Sistani led the company's transformation into a modern digital health organization and expanded its portfolio with the acquisition of Sequence (now WeightWatchers Clinic). Comonte, with her extensive executive leadership experience, is expected to guide the company's transformation, sharpen its strategic focus, and evolve its offerings to drive growth.
The company reaffirmed its full-year 2024 guidance for End of Period Subscribers, Revenue, Adjusted Operating Income, and Adjusted EBITDAS. The WeightWatchers Board of Directors has been reduced from nine to eight members following this transition.
WeightWatchers (NASDAQ: WW) ha annunciato un importante cambiamento di leadership il 27 settembre 2024. Tara Comonte, membro indipendente del consiglio, è stata nominata Amministratore Delegato Interinale, succedendo a Sima Sistani, che si dimette dai suoi ruoli di CEO e membro del consiglio.
Durante il suo mandato, Sistani ha guidato la trasformazione dell'azienda in un'organizzazione di salute digitale moderna e ha ampliato il suo portafoglio con l'acquisizione di Sequence (ora WeightWatchers Clinic). Comonte, grazie alla sua vasta esperienza dirigenziale, è attesa a guidare la trasformazione dell'azienda, affinare il suo focus strategico e sviluppare le sue offerte per stimolare la crescita.
L'azienda ha confermato le sue previsioni per l'intero anno 2024 riguardo al Numero di Abbonati alla Fine del Periodo, al Fatturato, all'Utilizzo Operativo Rettificato e all'EBITDAS Rettificato. Il Consiglio di Amministrazione di WeightWatchers è stato ridotto da nove a otto membri a seguito di questa transizione.
WeightWatchers (NASDAQ: WW) anunció un cambio significativo en su liderazgo el 27 de septiembre de 2024. Tara Comonte, miembro independiente de la junta, ha sido nombrada Directora Ejecutiva Interina, sucediendo a Sima Sistani, quien deja sus roles como CEO y miembro de la junta.
Durante su mandato, Sistani lideró la transformación de la empresa en una organización moderna de salud digital y amplió su cartera con la adquisición de Sequence (ahora WeightWatchers Clinic). Comonte, con su amplia experiencia en liderazgo ejecutivo, se espera que guíe la transformación de la empresa, agudice su enfoque estratégico y desarrolle sus ofertas para impulsar el crecimiento.
La empresa reafirmó sus previsiones para todo el año 2024 en cuanto a Número de Suscriptores al Final del Período, Ingresos, Ingreso Operativo Ajustado y EBITDA Ajustado. La Junta Directiva de WeightWatchers se ha reducido de nueve a ocho miembros tras esta transición.
WeightWatchers (NASDAQ: WW)는 2024년 9월 27일 중요한 리더십 변화를 발표했습니다. 타라 코몬트가 독립 이사로 임명되어 인터임 CEO로 취임하며, 시마 시스탄리는 CEO 및 이사직에서 물러납니다.
그녀의 재임 기간 동안, 시스탄리는 회사를 현대적인 디지털 헬스 조직으로 변화시키며 Sequence(현재 WeightWatchers Clinic)의 인수로 포트폴리오를 확장했습니다. 폭넓은 경영 경험을 가진 코몬트는 회사의 변화를 이끌고, 전략적 집중을 강화하며, 성장을 위해 제공하는 서비스를 발전시킬 것으로 기대됩니다.
회사는 2024년 전체 연도에 대한 최종 구독자 수, 수익, 조정된 운영 수익 및 조정 EBITDA에 대한 가이던스를 재확인했습니다. WeightWatchers 이사회는 이번 전환으로 인해 9명에서 8명으로 축소되었습니다.
WeightWatchers (NASDAQ: WW) a annoncé un changement de direction significatif le 27 septembre 2024. Tara Comonte, membre indépendant du conseil, a été nommée Directrice Générale par Intérim, succédant à Sima Sistani, qui quitte ses fonctions de PDG et de membre du conseil.
Durant son mandat, Sistani a dirigé la transformation de l'entreprise en une organisation moderne de santé numérique et a élargi son portefeuille par l'acquisition de Sequence (aujourd'hui WeightWatchers Clinic). Comonte, grâce à sa vaste expérience en leadership exécutif, est attendue pour guider la transformation de l'entreprise, affiner son axe stratégique et faire évoluer ses offres pour stimuler la croissance.
L'entreprise a confirmé ses prévisions de résultats pour l'année 2024 concernant le nombre d'abonnés à la fin de la période, le chiffre d'affaires, le résultat opérationnel ajusté et l'EBITDA ajusté. Le conseil d'administration de WeightWatchers a été réduit de neuf à huit membres à la suite de cette transition.
WeightWatchers (NASDAQ: WW) gab am 27. September 2024 einen bedeutenden Führungswechsel bekannt. Tara Comonte, ein unabhängiges Vorstandsmitglied, wurde zur
Während ihrer Amtszeit leitete Sistani die Transformation des Unternehmens zu einer modernen digitalen Gesundheitsorganisation und erweiterte ihr Portfolio durch die Übernahme von Sequence (jetzt WeightWatchers Clinic). Comonte, die über umfangreiche Führungserfahrung verfügt, wird erwartet, dass sie die Transformation des Unternehmens leitet, den strategischen Fokus schärft und die Angebote weiterentwickelt, um das Wachstum voranzutreiben.
Das Unternehmen bestätigte die Prognosen für das gesamte Jahr 2024 in Bezug auf die Anzahl der Abonnenten zum Ende des Zeitraums, den Umsatz, das bereinigte Betriebsergebnis und das bereinigte EBITDAS. Der Vorstand von WeightWatchers wurde nach diesem Übergang von neun auf acht Mitglieder reduziert.
- Appointment of experienced executive Tara Comonte as Interim CEO
- Reaffirmation of full-year 2024 financial guidance
- Expansion of offerings with WeightWatchers Clinic for clinical weight management solutions
- Departure of CEO Sima Sistani
- Reduction in board size from nine to eight members
Independent Board Member Tara Comonte Will Serve as Interim Chief Executive Officer
Sima Sistani Will Step Down as CEO and Director
NEW YORK, Sept. 27, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today that WeightWatchers Board member Tara Comonte has been appointed Interim Chief Executive Officer. Ms. Comonte succeeds Sima Sistani, who departs from her role as Chief Executive Officer and as a member of the Board, effective today.
During her tenure, Ms. Sistani led the Company’s transformation to a modern digital health organization and extended the Company’s portfolio of solutions into the telehealth space with the acquisition and integration of Sequence (now WeightWatchers Clinic). This expanded the Company’s offerings to include high-touch clinical weight management solutions alongside its science-backed behavioral programs.
“On behalf of the Board, I want to sincerely thank Sima for her leadership in advancing our strategy, for adding WeightWatchers Clinic to our offerings and for her unwavering commitment to our mission,” said Thilo Semmelbauer, Chairman of the WeightWatchers Board of Directors. “We wish her all the best in her future endeavors.”
Ms. Comonte steps into the role at a time when the Company is focused on improving its operational and financial performance while continuing to build on its product innovation and solutions for members. With extensive executive leadership experience in strategy, technology, operations, and finance, along with her deep familiarity with WeightWatchers as a Board member, she is well-equipped to guide the Company’s transformation, sharpen its strategic focus, and evolve its behavioral and clinical offerings to drive growth. Most recently, Ms. Comonte served as CEO of TMRW Life Sciences, and prior to that, President and CFO of Shake Shack. She also serves on the boards of Kindbody and Strava.
“The Board is pleased to welcome Tara as Interim Chief Executive Officer,” said Semmelbauer. “Her proven ability to lead cross-functional transformations and drive growth, coupled with her deep understanding of our mission and commitment to our members, give us full confidence that she is the right leader to steer WeightWatchers through this pivotal moment and position the Company for sustained success.”
“I am looking forward to partnering closely with the WeightWatchers’ leadership team and Board as we advance the Company’s strategy to expand access and care during this critical period of our transformation,” said Ms. Comonte. “WeightWatchers is a strong, globally recognized business with a proven track record of success and competitive leadership advantage. I am confident that we have the right team in place and are focused on the right strategies to drive growth while staying true to our mission to empower members to live healthier, longer lives.”
Ms. Comonte joined the WeightWatchers Board of Directors in June 2023. In connection with this announcement, the WeightWatchers Board of Directors has been reduced from nine to eight members.
The Company is reaffirming its previously stated full-year 2024 guidance with respect to End of Period Subscribers, Revenue, Adjusted Operating Income and Adjusted EBITDAS.
About WW International, Inc.
WeightWatchers is a human-centric technology company powered by our proven, science-based, clinically effective weight loss and weight management programs. For six decades, we have inspired millions of people to adopt healthy habits for real life. We combine technology and community to help members reach and sustain their goals on our programs. To learn more about the WeightWatchers approach to healthy living, please visit ww.com. For more information about our global business, visit our corporate website at corporate.ww.com.
This news release includes “forward-looking statements,” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, in particular, any guidance and any statements about the Company’s plans, strategies, objectives, initiatives, roadmap and prospects. The Company generally uses the words “may,” “will,” “could,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “intend,” “aim” and similar expressions in this news release to identify forward-looking statements. The Company bases these forward-looking statements on its current views with respect to future events and financial performance. Actual results could differ materially from those projected in the forward-looking statements. These forward-looking statements are subject to risks, uncertainties and assumptions that could cause the Company’s results to differ materially from those expressed or suggested in any forward-looking statement, including, among other things the risks and uncertainties detailed from time to time in our periodic reports filed with the United States Securities and Exchange Commission (the "SEC"), including the disclosure contained in Item 1A. Risk Factors in our 2023 Annual Report on Form 10-K filed with the SEC. Except as required by law, the Company does not undertake any obligation to update or revise these forward-looking statements to reflect new information or events or circumstances that occur after the date of this news release or to reflect the occurrence of unanticipated events or otherwise. Readers are advised to review the Company’s filings with the SEC (which are available on the SEC’s EDGAR database at www.sec.gov and via the Company’s website at http://corporate.ww.com).
For more information, contact:
Media:
Kelsey Merkel
Communications@ww.com
Investors:
John Mills or Anna Kate Heller
WeightWatchers@icrinc.com
FAQ
Who is the new Interim CEO of WeightWatchers (WW)?
Why did Sima Sistani step down as CEO of WeightWatchers (WW)?
What changes did WeightWatchers (WW) make to its board of directors?
Has WeightWatchers (WW) changed its financial guidance for 2024?
